These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6801366)

  • 1. Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum (II) in bacteria and mice.
    Ishizawa M; Taniguchi S; Baba T
    Jpn J Pharmacol; 1981 Dec; 31(6):883-9. PubMed ID: 6801366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.
    Howell SB; Taetle R
    Cancer Treat Rep; 1980; 64(4-5):611-6. PubMed ID: 7191778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of cis-diamminedichloroplatinum (II) in blood and protection of its toxicity by sodium thiosulfate in rabbits.
    Iwamoto Y; Kawano T; Ishizawa M; Aoki K; Kuroiwa T; Baba T
    Cancer Chemother Pharmacol; 1985; 15(3):228-32. PubMed ID: 3902266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.
    Uozumi J; Ishizawa M; Iwamoto Y; Baba T
    Cancer Chemother Pharmacol; 1984; 13(2):82-5. PubMed ID: 6540631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of cis-diamminedichloroplatinum (II) in blood by sodium thiosulfate.
    Abe R; Akiyoshi T; Baba T
    Oncology; 1990; 47(1):65-9. PubMed ID: 2300388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of antiproliferative effect of cis-diamminedichloroplatinum (II) by sodium thiosulfate.
    Abe R; Akiyoshi T; Tsuji H; Baba T
    Cancer Chemother Pharmacol; 1986; 18(2):98-100. PubMed ID: 3791566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Two route chemotherapy" using cis-diamminedichloro-platinum(II) and its antidote, sodium thiosulfate, for peritoneally disseminated cancer in rats.
    Taniguchi S; Baba T
    Gan; 1982 Jun; 73(3):475-9. PubMed ID: 6890002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cis-diamminedichloroplatinum(II)-induced sister-chromatid exchanges and chromosome aberration formation in cultured human lymphocytes and their inhibition by sodium thiosulfate.
    Ohe T; Tsuda S; Sakata Y; Taniwaki M; Misawa S; Abe T
    Mutat Res; 1990 Aug; 244(4):279-85. PubMed ID: 2385243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin.
    Wagner T; Kreft B; Bohlmann G; Schwieder G
    J Cancer Res Clin Oncol; 1988; 114(5):497-501. PubMed ID: 3141427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two-route chemotherapy using the anticancer drug cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate].
    Kuroiwa T; Baba T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1011-7. PubMed ID: 3566300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Two-route chemotherapy" using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, combined with angiotensin II is effective against peritoneally disseminated cancer in rats.
    Kobayashi H; Hasuda K; Aoki K; Kuroiwa T; Taniguchi S; Baba T
    Cancer Chemother Pharmacol; 1989; 24(3):141-7. PubMed ID: 2736707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
    Vadi H; Drewinko B
    Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
    Satoh M; Naganuma A; Imura N
    Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of dithiocarbamates against toxicity of cis-diamminedichloroplatinum in mice.
    Shimada H; Takahashi K; Funakoshi T; Kojima S
    Biol Pharm Bull; 1993 Apr; 16(4):368-71. PubMed ID: 8358386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
    Naganuma A; Satoh M; Imura N
    Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
    Satoh M; Naganuma A; Imura N
    J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
    Bodenner DL; Dedon PC; Keng PC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2745-50. PubMed ID: 2870800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced mutagenesis during post-treatment incubation of Escherichia coli treated with cis-diamminedichloroplatinum(II).
    Razaka H; Villani G; Hoffman JS; Defais M; Johnson NP
    Mutat Res; 1988; 209(1-2):63-6. PubMed ID: 3140004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of an E. coli strain resistant to the toxic and mutagenic action of cis-diamminedichloroplatinum(II).
    Villani G; Lherisson C; Defais M; Johnson NP
    Mutat Res; 1987 Jan; 183(1):21-9. PubMed ID: 3540652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy in tumor-bearing rats using high-dose cis-diamminedichloroplatinum(II) with low nephrotoxicity in combination with angiotensin II and sodium thiosulfate.
    Kobayashi H; Hasuda K; Aoki K; Taniguchi S; Baba T
    Int J Cancer; 1990 May; 45(5):940-4. PubMed ID: 2335397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.